Humana 2012 Annual Report Download - page 146

Download and view the complete annual report

Please find page 146 of the 2012 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

Material Changes to the Procedures by which Security Holders May Recommend Nominees to the
Registrant’s Board of Directors
None.
Audit Committee Financial Expert
The information required by this Item is herein incorporated by reference from our Proxy Statement for the
Annual Meeting of Stockholders scheduled to be held on April 25, 2013 appearing under the caption “Corporate
Governance – Audit Committee” of such Proxy Statement.
Audit Committee Composition and Independence
The information required by this Item is herein incorporated by reference from our Proxy Statement for the
Annual Meeting of Stockholders scheduled to be held on April 25, 2013 appearing under the caption “Corporate
Governance – Committee Composition” of such Proxy Statement.
ITEM 11. EXECUTIVE COMPENSATION
Additional information required by this Item is incorporated herein by reference from our Proxy Statement
for the Annual Meeting of Stockholders scheduled to be held on April 25, 2013 appearing under the captions
“Corporate Governance – Organization & Compensation Committee – Compensation Committee Interlocks and
Insider Participation,” “Director Compensation,” “Compensation Discussion and Analysis,” “Organization &
Compensation Committee Report,” and “Executive Compensation” of such Proxy Statement.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
Equity compensation plan information
We maintain plans under which options to purchase our common stock and under which awards of restricted
stock may be made to officers, directors, key employees, and consultants. Stock options are granted with an
exercise price equal to the fair market value of the underlying common stock on the date of grant. Our stock
plans, as approved by the Board of Directors and stockholders, define fair market value as the average of the
highest and lowest composite stock prices reported by the New York Stock Exchange on a given date. Exercise
provisions vary, but most options vest in whole or in part 1 to 3 years after grant and expire 7 to 10 years after
grant.
Information concerning stock option awards and the number of securities remaining available for future
issuance under our equity compensation plans in effect as of December 31, 2012 follows:
Plan category
(a)
Number of securities
to be issued upon
exercise of outstanding
options, warrants
and rights
(b)
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(c)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column(a))
Equity compensation plans approved by security
holders (1) ............................ 2,232,800 $61.6807 17,223,584 (2)(3)
Equity compensation plans not approved by
security holders ........................ 0 0 0
Total .............................. 2,232,800 $61.6807 17,223,584
(1) The above table does not include awards of shares of restricted stock or restricted stock units. For
information concerning these awards, see Note 12.
136